Wednesday, 20 February 2019

FDA warning brings controversial young blood transfusion company to a halt

FDA warning brings controversial young blood transfusion company to a halt

On Tuesday, the FDA issued a warning to anyone who might be inclined to give their old bones a jolt with fresh blood harvested from the young. The idea is pretty far from mainstream, even in Silicon Valley, where the ultra-wealthy have a keen interest in the cutting edge of life-extension science. …

Continue reading...

No comments:

Post a Comment